Celldex Therapeutics, Inc.
DE ˙ DB ˙ US15117B2025
25,28 € ↑0,78 (3,18%)
2026-06-04
DEL PRIS
SecurityDE:TCE2 / Celldex Therapeutics, Inc.
InstitutionMorgan Stanley
Latest Disclosed Ownership217,549 shares
Latest Disclosed Value $ 6,900,673
Morgan Stanley reports 23.81% decrease in ownership of TCE2 / Celldex Therapeutics, Inc.

On May 15, 2026 - Morgan Stanley filed a 13F-HR form disclosing ownership of 217,549 shares of Celldex Therapeutics, Inc. (DE:TCE2) valued at $5,569,254 USD as of March 31, 2026. The entity filed a previous 13F-HR/A on May 27, 2026 disclosing 285,535 shares of Celldex Therapeutics, Inc.. This represents a change in shares of -23.81% during the quarter. The current value of the position is $5,499,639 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F CELLDEX THERAPEUTICS INC COM NEW 15117B202 217,549 -67,986 -23.81 6,901 -11.03 0.0004
2026-05-27 2025-12-31 13F/A-1 CELLDEX THERAPEUTICS INC COM NEW 15117B202 285,535 -26,384 -8.46 7,755 -3.89 0.0005
2026-02-13 2025-12-31 13F CELLDEX THERAPEUTICS INC COM NEW 15117B202 285,535 -26,384 7,755 0.0005
2026-05-27 2025-09-30 13F/A-1 CELLDEX THERAPEUTICS INC COM NEW 15117B202 311,919 -349,599 -52.85 8,069 -40.06 0.0005
2025-11-14 2025-09-30 13F CELLDEX THERAPEUTICS INC COM NEW 15117B202 311,919 -349,599 8,069 0.0005
2025-08-15 2025-06-30 13F CELLDEX THERAPEUTICS INC COM NEW 15117B202 661,518 -241,364 -26.73 13,462 -17.86 0.0009
2025-05-15 2025-03-31 13F CELLDEX THERAPEUTICS INC COM NEW 15117B202 902,882 -441,217 -32.83 16,387 -51.75 0.0012
2025-05-15 2024-12-31 13F/A-1 CELLDEX THERAPEUTICS INC COM NEW 15117B202 1,344,099 908,281 208.41 33,965 129.29 0.0024
2025-02-14 2024-12-31 13F CELLDEX THERAPEUTICS INC COM NEW 15117B202 1,344,099 908,281 33,965 0.0024
2025-05-14 2024-09-30 13F/A-2 CELLDEX THERAPEUTICS INC COM NEW 15117B202 435,818 271,826 165.76 14,813 144.08 0.0011
2025-02-14 2024-09-30 13F/A-1 CELLDEX THERAPEUTICS INC COM NEW 15117B202 435,818 271,826 14,813 0.0011
2024-11-14 2024-09-30 13F CELLDEX THERAPEUTICS INC COM NEW 15117B202 435,818 271,826 14,813 0.0001
2025-05-14 2024-06-30 13F/A-2 CELLDEX THERAPEUTICS INC COM NEW 15117B202 163,992 -212,129 -56.40 6,069 -61.55 0.0005
2024-10-17 2024-06-30 13F/A-1 CELLDEX THERAPEUTICS INC COM NEW 15117B202 163,992 -212,129 6,069 0.0005
2024-08-14 2024-06-30 13F CELLDEX THERAPEUTICS INC COM NEW 15117B202 163,992 -212,129 6,069 0.0005
2024-10-17 2024-03-31 13F/A-2 CELLDEX THERAPEUTICS INC COM NEW 15117B202 376,121 -282,244 -42.87 15,786 -39.54 0.0013
2024-08-16 2024-03-31 13F/A-1 CELLDEX THERAPEUTICS INC COM NEW 15117B202 376,121 -282,244 15,786 0.0013
2024-05-15 2024-03-31 13F CELLDEX THERAPEUTICS INC COM NEW 15117B202 376,121 -282,244 15,786 0.0013
2024-08-16 2023-12-31 13F/A-1 CELLDEX THERAPEUTICS INC COM NEW 15117B202 658,365 134,665 25.71 26,111 81.17 0.0023
2024-02-13 2023-12-31 13F CELLDEX THERAPEUTICS INC COM NEW 15117B202 658,365 134,665 26,111 0.0023
2023-11-15 2023-09-30 13F CELLDEX THERAPEUTICS INC COM NEW 15117B202 523,700 385,916 280.09 14,412 208.28 0.0015
2023-08-14 2023-06-30 13F CELLDEX THERAPEUTICS INC COM NEW 15117B202 137,784 -355,261 -72.05 4,675 -73.65 0.0005
2023-05-15 2023-03-31 13F CELLDEX THERAPEUTICS INC COM NEW 15117B202 493,045 289,356 142.06 17,740 95.41 0.0019
2023-02-14 2022-12-31 13F CELLDEX THERAPEUTICS INC COM NEW 15117B202 203,689 306 0.15 9,078 58.73 0.0010
2022-11-14 2022-09-30 13F CELLDEX THERAPEUTICS INC COM NEW 15117B202 203,383 -278,644 -57.81 5,719 -55.99 0.0008
2022-10-27 2022-06-30 13F/A-1 CELLDEX THERAPEUTICS INC COM NEW 15117B202 482,027 -536,997 -52.70 12,995 -62.56 0.0017
2022-08-15 2022-06-30 13F CELLDEX THERAPEUTICS INC COM NEW 15117B202 482,027 -536,997 12,995 0.0003
2022-10-27 2022-03-31 13F/A-1 CELLDEX THERAPEUTICS INC COM NEW 15117B202 1,019,024 713,091 233.09 34,708 193.61 0.0047
2022-05-13 2022-03-31 13F CELLDEX THERAPEUTICS INC COM NEW 15117B202 1,019,024 713,091 34,708 0.0047
2022-02-14 2021-12-31 13F CELLDEX THERAPEUTICS INC COM NEW 15117B202 305,933 128,397 72.32 11,821 23.34 0.0015
2021-11-15 2021-09-30 13F CELLDEX THERAPEUTICS INC COM NEW 15117B202 177,536 54,377 44.15 9,584 132.73 0.0013
2021-08-23 2021-06-30 13F/A-1 CELLDEX THERAPEUTICS INC COM NEW 15117B202 123,159 101,154 459.69 4,118 809.05 0.0005
2021-08-16 2021-06-30 13F CELLDEX THERAPEUTICS INC COM NEW 15117B202 123,159 101,154 4,118 0.0001
2021-05-17 2021-03-31 13F CELLDEX THERAPEUTICS INC COM NEW 15117B202 22,005 2,459 12.58 453 32.07 0.0001
2021-02-16 2020-12-31 13F CELLDEX THERAPEUTICS INC COM NEW 15117B202 19,546 3,667 23.09 343 45.34 0.0001
2020-11-13 2020-09-30 13F CELLDEX THERAPEUTICS INC COM NEW 15117B202 15,879 -7,263 -31.38 236 -21.59 0.0000
2020-08-14 2020-06-30 13F CELLDEX THERAPEUTICS INC COM NEW 15117B202 23,142 3,639 18.66 301 812.12 0.0001
2020-05-26 2020-03-31 13F/A-1 CELLDEX THERAPEUTICS INC COM NEW 15117B202 19,503 -1,667 -7.87 33 -31.25 0.0000
2020-05-15 2020-03-31 13F CELLDEX THERAPEUTICS INC COM NEW 15117B202 19,503 -1,667 33 2.5351
2020-02-14 2019-12-31 13F CELLDEX THERAPEUTICS INC COM NEW 15117B202 21,170 11,724 124.12 48 140.00 0.0000
2019-11-14 2019-09-30 13F CELLDEX THERAPEUTICS INC COM NEW 15117B202 9,446 -1,686 -15.15 20 -33.33 0.0000
2019-08-14 2019-06-30 13F CELLDEX THERAPEUTICS INC COM NEW 15117B202 11,132 8,774 372.09 30 172.73 0.0000
2019-05-15 2019-03-31 13F CELLDEX THERAPEUTICS INC COM NEW 15117B202 2,358 -84,181 -97.28 11 -35.29 0.0000
2019-02-14 2018-12-31 13F CELLDEX THERAPEUTICS INC COM 15117B103 86,539 44,342 105.08 17 -15.00 0.0000
2019-04-23 2018-09-30 13F/A-2 CELLDEX THERAPEUTICS INC COM 15117B103 42,197 -467,353 -91.72 20 -92.19 0.0000
2018-11-20 2018-09-30 13F/A-1 CELLDEX THERAPEUTICS INC COM 15117B103 42,197 0 20 0.0000
2018-11-14 2018-09-30 13F CELLDEX THERAPEUTICS INC COM 15117B103 42,197 -467,353 20
2019-04-23 2018-06-30 13F/A-1 CELLDEX THERAPEUTICS INC COM 15117B103 509,550 -36,601 -6.70 256 -79.87 0.0001
2018-08-14 2018-06-30 13F CELLDEX THERAPEUTICS INC COM 15117B103 509,550 -36,601 256
2019-04-23 2018-03-31 13F/A-1 CELLDEX THERAPEUTICS INC COM 15117B103 546,151 112,583 25.97 1,272 3.33 0.0004
2018-05-14 2018-03-31 13F CELLDEX THERAPEUTICS INC COM 15117B103 546,151 112,583 1,272
2019-04-23 2017-12-31 13F/A-1 CELLDEX THERAPEUTICS INC COM 15117B103 433,568 -105,572 -19.58 1,231 -20.17 0.0003
2018-02-14 2017-12-31 13F CELLDEX THERAPEUTICS INC COM 15117B103 433,568 -105,572 1,231
2017-11-14 2017-09-30 13F CELLDEX THERAPEUTICS INC COM 15117B103 539,140 52,244 10.73 1,542 28.18 0.0005
2017-08-11 2017-06-30 13F CELLDEX THERAPEUTICS INC COM 15117B103 486,896 -21,509 -4.23 1,203 -34.44 0.0004
2017-05-22 2017-03-31 13F/A-1 CELLDEX THERAPEUTICS INC COM 15117B103 508,405 -181,486 -26.31 1,835 -24.86 0.0006
2017-05-12 2017-03-31 13F CELLDEX THERAPEUTICS INC COM 15117B103 508,405 1,835
2017-02-22 2016-12-31 13F/A-1 CELLDEX THERAPEUTICS INC COM 15117B103 689,891 -27,681 -3.86 2,442 -15.76 0.0008
2017-02-13 2016-12-31 13F CELLDEX THERAPEUTICS INC COM 15117B103 689,891 2,442
2016-11-10 2016-09-30 13F CELLDEX THERAPEUTICS INC COM 15117B103 717,572 133,659 22.89 2,899 13.11 0.0010
2016-08-12 2016-06-30 13F CELLDEX THERAPEUTICS INC COM 15117B103 583,913 22,822 4.07 2,563 20.84 0.0009
2016-05-12 2016-03-31 13F CELLDEX THERAPEUTICS INC COM 15117B103 561,091 -243,267 -30.24 2,121 -83.18 0.0008
2016-02-09 2015-12-31 13F CELLDEX THERAPEUTICS INC COM 15117B103 804,358 1,820 0.23 12,611 49.12 0.0046
2016-02-08 2015-09-30 13F/A-1 CELLDEX THERAPEUTICS INC COM 15117B103 802,538 -61,859 -7.16 8,457 -61.21 0.0031
2015-11-09 2015-09-30 13F CELLDEX THERAPEUTICS INC COM 15117B103 802,538 8,457
2015-08-12 2015-06-30 13F CELLDEX THERAPEUTICS INC COM 15117B103 864,397 10,135 1.19 21,801 -8.43 0.0076
2015-05-14 2015-03-31 13F CELLDEX THERAPEUTICS INC COM 15117B103 854,262 -55,501 -6.10 23,809 43.40 0.0088
2015-02-13 2014-12-31 13F CELLDEX THERAPEUTICS INC COM 15117B103 909,763 133,433 17.19 16,603 65.02 0.0061
2014-12-16 2014-09-30 13F/A-1 CELLDEX THERAPEUTICS INC COM 15117B103 776,330 -72,966 -8.59 10,061 -27.41 0.0039
2014-11-14 2014-09-30 13F CELLDEX THERAPEUTICS INC COM 15117B103 776,330 10,061
2014-08-12 2014-06-30 13F CELLDEX THERAPEUTICS INC COM 15117B103 849,296 102,542 13.73 13,860 5.04 0.0237
2014-05-13 2014-03-31 13F CELLDEX THERAPEUTICS INC COM 15117B103 746,754 106,198 16.58 13,195 -14.91 0.0055
2014-02-13 2013-12-31 13F CELLDEX THERAPEUTICS INC COM 15117B103 640,556 80,198 14.31 15,507 -21.90 0.0066
2013-11-13 2013-09-30 13F CELLDEX THERAPEUTICS INC COM 15117B103 560,358 24,784 4.63 19,855 137.50 0.0094
2013-08-08 2013-06-30 13F CELLDEX THERAPEUTICS INC COM 15117B103 535,574 535,574 8,360 0.0042
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.